{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T07:21:53Z","timestamp":1648797713660},"reference-count":36,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.cjca.2013.09.010","type":"journal-article","created":{"date-parts":[[2013,10,30]],"date-time":"2013-10-30T06:03:05Z","timestamp":1383112985000},"page":"1371-1373","source":"Crossref","is-referenced-by-count":1,"title":["Even Mild Kidney Dysfunction Is an Important Cardiovascular Risk Predictor: Implications and Challenges"],"prefix":"10.1016","volume":"29","author":[{"given":"Sofia B.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle C.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda R.","family":"Hemmelgarn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2013.09.010_bib1","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/sj.ki.5000446","article-title":"Characteristics of sudden death in hemodialysis patients","volume":"69","author":"Bleyer","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2013.09.010_bib2","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction","volume":"351","author":"Anavekar","year":"2004","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cjca.2013.09.010_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1525-139X.2003.160271.x","article-title":"Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure","volume":"16","author":"Foley","year":"2003","journal-title":"Semin Dial"},{"key":"10.1016\/j.cjca.2013.09.010_bib4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2004030203","article-title":"Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999","volume":"16","author":"Foley","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cjca.2013.09.010_bib5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1525-139X.2008.00455.x","article-title":"Sudden cardiac death and dialysis patients","volume":"21","author":"Herzog","year":"2008","journal-title":"Semin Dial"},{"key":"10.1016\/j.cjca.2013.09.010_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1054\/jcaf.2003.10","article-title":"Beware the rising creatinine level","volume":"9","author":"Shlipak","year":"2003","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.cjca.2013.09.010_bib7","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1097\/01.ASN.0000135969.33773.0B","article-title":"\u201cRenalism\u201d: inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency","volume":"15","author":"Chertow","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cjca.2013.09.010_bib8","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1503\/cmaj.080351","article-title":"Guidelines for the management of chronic kidney disease","volume":"179","author":"Levin","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.cjca.2013.09.010_bib9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1046\/j.1525-139X.2003.16028.x","article-title":"Traditional cardiac risk factors in individuals with chronic kidney disease","volume":"16","author":"Uhlig","year":"2003","journal-title":"Semin Dial"},{"key":"10.1016\/j.cjca.2013.09.010_bib10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.ki.5002343","article-title":"Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes","volume":"72","author":"Levey","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2013.09.010_bib11","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cjca.2013.09.010_bib12","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.cjca.2012.10.014","article-title":"Impact of estimated glomerular filtration rate on vascular disease extent and adverse cardiovascular events in patients without chronic kidney disease","volume":"29","author":"Arbel","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2013.09.010_bib13","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2013.09.010_bib14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.cjca.2012.02.018","article-title":"The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy","volume":"28","author":"Daskalopoulou","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2013.09.010_bib15","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.cjca.2011.04.004","article-title":"The relationship between kidney function and angiographically-derived SYNTAX score","volume":"27","author":"Yan","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2013.09.010_bib16","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1161\/CIRCULATIONAHA.105.609974","article-title":"Prevalence and determinants of troponin T elevation in the general population","volume":"113","author":"Wallace","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2013.09.010_bib17","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1056\/NEJMoa013456","article-title":"Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction","volume":"346","author":"Aviles","year":"2002","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cjca.2013.09.010_bib18","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1161\/CIRCULATIONAHA.105.560128","article-title":"Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis","volume":"112","author":"Khan","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2013.09.010_bib19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.CIR.0000020222.63035.C0","article-title":"Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure","volume":"106","author":"Oh","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2013.09.010_bib20","series-title":"U.S. Renal Data System, USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States","year":"2011"},{"key":"10.1016\/j.cjca.2013.09.010_bib21","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2215\/CJN.03080410","article-title":"Determinants of cardiac autonomic dysfunction in ESRD","volume":"5","author":"Chan","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cjca.2013.09.010_bib22","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1152\/japplphysiol.01207.2011","article-title":"Impact of gender on the cardiac autonomic response to angiotensin II in healthy humans","volume":"112","author":"Mann","year":"2012","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.cjca.2013.09.010_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.cll.2006.06.005","article-title":"Microalbuminuria","volume":"26","author":"Khosla","year":"2006","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.cjca.2013.09.010_bib24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/jama.2010.39","article-title":"Relation between kidney function, proteinuria, and adverse outcomes","volume":"303","author":"Hemmelgarn","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2013.09.010_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-154-1-201101040-00003","article-title":"Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study","volume":"154","author":"Tonelli","year":"2011","journal-title":"Ann Int Med"},{"key":"10.1016\/j.cjca.2013.09.010_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCULATIONAHA.105.592733","article-title":"Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial","volume":"114","author":"Solomon","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2013.09.010_bib27","first-page":"F526","article-title":"Increased urinary protein excretion in the \u201cnormal\u201d range is associated with increased renin-angiotensin system activity","volume":"302","author":"Nicholl","year":"2012","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cjca.2013.09.010_bib28","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2013.09.010_bib29","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/eurheartj\/eht065","article-title":"Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"34","author":"Hou","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2013.09.010_bib30","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jacc.2011.06.010","article-title":"Chronic kidney disease and cardiovascular therapeutics: time to close the evidence gaps","volume":"58","author":"Chang","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2013.09.010_bib31","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cjca.2013.09.010_bib32","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1056\/NEJMoa1208799","article-title":"Cardiorenal end points in a trial of aliskiren for type 2 diabetes","volume":"367","author":"Parving","year":"2012","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cjca.2013.09.010_bib33","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000346948","article-title":"Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)","volume":"37","author":"de Zeeuw","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.cjca.2013.09.010_bib34","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ki.2011.223","article-title":"Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"80","author":"Herzog","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2013.09.010_bib35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cjca.2011.11.005","article-title":"The sympathetic nervous system and new nonpharmacologic approaches to treating hypertension: a focus on renal denervation","volume":"28","author":"Grassi","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2013.09.010_bib36","unstructured":"The Kidney Foundation of Canada. Facing the Facts - 2012. Available at: http:\/\/www.kidney.ca\/document.doc?id=1376. Accessed December 10,\u00a02012."}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X13014207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X13014207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T07:50:38Z","timestamp":1539244238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X13014207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0828282X13014207"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2013.09.010","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}